Research suggests that the available published studies on Magnolia bark compounds do not directly address weight management. The two identified studies — both preclinical investigations conducted in cell lines and mouse models — examined obovatol and magnolol in the context of cancer biology, specifically liver cancer immune evasion and radiation sensitization in oral cancer, respectively. Neither study measured or reported outcomes related to body weight, fat metabolism, appetite, or any other parameter relevant to weight management. Readers looking for evidence on Magnolia bark and weight management should be aware that the current linked body of research does not support drawing conclusions in that area, and that any such claims would require separate, targeted human or animal studies focused specifically on metabolic outcomes.
Citations from PubMed and preprint sources. Match score (0-100) reflects automated search ranking, not clinical appraisal.
| Title | Type | Year | Direction | Match |
|---|---|---|---|---|
| Obovatol inhibits proliferation, invasion and immune escape of hepatocellular... | Other | 2024 | Neutral | 72 |
| Magnolol as a Radiotherapy Enhancer in Oral Squamous Cell Carcinoma: Targetin... | Other | 2025 | Neutral | 67 |